United Kingdom · Question · Written question
UIN 178754
Mercaptamine
Introduced
12 April 2021
Last action
22 April 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 April 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment has been made of the potential merits of making mercaptamine hydrochloride eye drops available through the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 April 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment has been made of the potential merits of making mercaptamine hydrochloride eye drops available through the NHS.
Source: Commons
22 April 2021
Answer
Current clinical commissioning policy is that mercaptamine hydrochloride eye drops are not recommended to be available as a treatment option through routine commissioning for corneal cystine deposits, following the prioritisation process undertaken by NHS...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-04-12/178754
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1307703
- uk · wq-1307703 · source updated 22 April 2021